Investors
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.
Quarterly Results
We announced our results for the first quarter ended on 2 April 2022 on Thursday 28 April 2022.
Listen to the quarterly results presentation
Replay the webcast of our first quarter results presentation to analysts.
Up and coming event
Annual General Meeting 2022
13 April 2022 Watford, UK
Event details
The Annual General Meeting (AGM) of Smith & Nephew plc (the 'Company') was held on Wednesday 13 April 2022 at Smith+Nephew's Expert Connect Centre, Building 5, Croxley Park, Hatters Lane, Watford, WD18 8YE.
Investor Resources
Sustainability
As a portfolio medical technology company, Smith+Nephew’s purpose is to restore and promote health and wellbeing.
We believe that this applies not just to the benefits our products deliver to patients, but also to the wider health of the planet and society.